Funds holding Artelo Biosciences Inc
ISIN US04301G7060 · United States
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- 11.7K $
- Share of capital
- 0.0 % of 4.6M shares on Aug 11, 2026
A single tracked fund declares this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,538 | 11.7K $ | 0.03 % | as of Mar 31, 2026 ↗ |
Institutional managers
8 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Kathmere Capital Management, LLC | 13,250 | 100.4K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 13,079 | 99.1K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 3,076 | 23.3K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 2,826 | 21.4K $ | as of Mar 31, 2026 |
| Clear Street Group Inc. | 100 | 758 $ | as of Mar 31, 2026 |
| ROTHSCHILD INVESTMENT LLC | 2 | 15 $ | as of Mar 31, 2026 |
| CWM, LLC | 1 | 8 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 1 | 7 $ | as of Mar 31, 2026 |
Declared shareholders of Artelo Biosciences Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Armistice Capital, LLC and 1 other | 9.99 % | 235,823 | as of Mar 31, 2026 · SCHEDULE 13G |
| Mitchell P. Kopin and 2 others | 9.99 % | 81,701 | as of Mar 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Artelo Biosciences Inc". https://titelia.com/en/stocks/artelo-biosciences-inc-US04301G7060